Results 151 to 160 of about 3,191 (210)

Effectiveness of Acupuncture and Moxibustion for Non-Small Cell Lung Cancer (NSCLC) Patients Undergoing Standard Treatment: A Systematic Review and Meta-Analysis. [PDF]

Integr Cancer Ther
Kim DH, Park MS, Lee KJ, Kwon JH, Jin YJ, Park SJ.   +5 more
europepmc   +1 more source

Development of a large language model-based knowledge graph for chemotherapy-induced nausea and vomiting in breast cancer and its implications for nursing. [PDF]

Int J Nurs Sci
Liu Y, Chen J, Lin X, Song J, Chen S.
europepmc   +1 more source

Do Not Throw Away Your Patient's Shot at Complete Vomiting Control. [PDF]

J Pediatr Pharmacol Ther
Dupuis LL, Patel P.
europepmc   +1 more source

The effect of Citrus aurantium inhalation aromatherapy on chemotherapy-induced nausea and vomiting in breast cancer patients: a randomized controlled trial. [PDF]

BMC Complement Med Ther
Tabei P, Molazem Z, Rivaz M, Maghami PG, Ahmadloo N.   +4 more
europepmc   +1 more source

Risk factors associated with anticipatory nausea and vomiting in children receiving chemotherapy: a cross-sectional study. [PDF]

Support Care Cancer
Fan J, Zhou Y, Bai G, Chu X, Di J, Yu L.
europepmc   +1 more source

Prospective observational study on chemotherapy-induced nausea and vomiting (CINV) for colorectal cancer patients by the CINV study group of Japan. [PDF]

Journal of Clinical Oncology, 2014
652 Background: The aim of this study is to investigate the incidence of Chemotherapy Induced Nausea and Vomiting (CINV) among moderately emetogenic chemotherapy-naive patients with colorectal cancer. We also assessed whether the medical staff accurately recognized the incidence of CINV in their own practices.
Yuji Miyamoto, Hideo Baba, Yasushi Tsuji, Ayako Doi, Koji Takeda, Michiya Kobayashi, Yoshihiko Maehara, Masahiro Gotoh, Kazuhiro Yoshida, Norihiro Kokudo, Yoshihiro Kakeji, Keisuke Aiba   +11 more
openaire   +2 more sources

Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries [PDF]

Supportive Care in Cancer, 2014
This paper describes the incidence of chemotherapy-induced nausea and vomiting (CINV) after highly or moderately emetogenic chemotherapy (HEC or MEC) for cancer in six Asia Pacific countries.Sequential adult patients naïve to chemotherapy and scheduled to receive at least two cycles of single-day HEC or MEC were enrolled in this prospective ...
Hsieh, R., Chan, A., Kim, H., Yu, S., Kim, J., Lee, M., Dalén, J., Jung, H., Liu, Y., Burke, T., Keefe, D.   +10 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan

Expert Opinion on Pharmacotherapy, 2017
Chemotherapy is an indispensable therapeutic approach for colorectal cancer both in the adjuvant and metastatic setting. Although chemotherapy-induced nausea and vomiting (CINV) is one of the most crucial adverse events, many aspects of CINV in patients with colorectal cancer remain unclear.This multicenter, prospective, observational study analyzed ...
Yuki Kitano, Yoshihiro Kakeji, Eiji Oki   +2 more
exaly   +3 more sources

Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) – is there still a role after comparison with palonosetron? [PDF]

Expert Opinion on Pharmacotherapy, 2017
Introduction\ud \ud Chemotherapy-induced nausea and vomiting (CINV) has a negative impact on the lives of subjects receiving chemotherapy. In 2009, the second generation 5-HT3-receptor antagonist, palonosetron, which is long-acting than granisetron, was

exaly   +2 more sources